Modeling the Growth and Decline of Pathogen Effective Population Size Provides Insight into Epidemic Dynamics and Drivers of Antimicrobial Resistance

Abstract Nonparametric population genetic modeling provides a simple and flexible approach for studying demographic history and epidemic dynamics using pathogen sequence data. Existing Bayesian approaches are premised on stochastic processes with stationary increments which may provide an unrealistic prior for epidemic histories which feature extended period of exponential growth or decline. We show that nonparametric models defined in terms of the growth rate of the effective population size can provide a more realistic prior for epidemic history. We propose a nonparametric autoregressive model on the growth rate as a prior for effective population size, which corresponds to the dynamics expected under many epidemic situations. We demonstrate the use of this model within a Bayesian phylodynamic inference framework. Our method correctly reconstructs trends of epidemic growth and decline from pathogen genealogies even when genealogical data are sparse and conventional skyline estimators erroneously predict stable population size. We also propose a regression approach for relating growth rates of pathogen effective population size and time‐varying variables that may impact the replicative fitness of a pathogen. The model is applied to real data from rabies virus and Staphylococcus aureus epidemics. We find a close correspondence between the estimated growth rates of a lineage of methicillin‐resistant S. aureus and population‐level prescription rates of Symbol‐lactam antibiotics. The new models are implemented in an open source R package called skygrowth which is available at https://github.com/mrc‐ide/skygrowth. Symbol. No caption available.

[1]  Iraida E. Robledo,et al.  Range Expansion and the Origin of USA300 North American Epidemic Methicillin-Resistant Staphylococcus aureus , 2018, mBio.

[2]  L. Allen An Introduction to Stochastic Epidemic Models , 2008 .

[3]  Mandev S. Gill,et al.  Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. , 2013, Molecular biology and evolution.

[4]  S. Ho,et al.  Skyline‐plot methods for estimating demographic history from nucleotide sequences , 2011, Molecular ecology resources.

[5]  H. Michel,et al.  Identification and Characterization of the Novel Subunit CcoM in the cbb3-Cytochrome c Oxidase from Pseudomonas stutzeri ZoBell , 2016, mBio.

[6]  Paolo Piazza,et al.  Microevolutionary analysis of Clostridium difficile genomes to investigate transmission , 2012, Genome Biology.

[7]  O. Pybus,et al.  An integrated framework for the inference of viral population history from reconstructed genealogies. , 2000, Genetics.

[8]  M. Suchard,et al.  Bayesian Phylogenetics with BEAUti and the BEAST 1.7 , 2012, Molecular biology and evolution.

[9]  Lee H Harrison,et al.  National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. , 2013, JAMA internal medicine.

[10]  Leslie A Real,et al.  A high-resolution genetic signature of demographic and spatial expansion in epizootic rabies virus , 2007, Proceedings of the National Academy of Sciences.

[11]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. , 2009, The Journal of antimicrobial chemotherapy.

[12]  K. Strimmer,et al.  Exploring the demographic history of DNA sequences using the generalized skyline plot. , 2001, Molecular biology and evolution.

[13]  R. Anderson,et al.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Julian Parkhill,et al.  Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community , 2014, Proceedings of the National Academy of Sciences.

[15]  Vladimir N. Minin,et al.  Quantifying and Mitigating the Effect of Preferential Sampling on Phylodynamic Inference , 2015, PLoS Comput. Biol..

[16]  C. Fraser Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic , 2007, PloS one.

[17]  Noah A. Rosenberg,et al.  Genealogical trees, coalescent theory and the analysis of genetic polymorphisms , 2002, Nature Reviews Genetics.

[18]  Daniel J. Wilson,et al.  Coalescent inference for infectious disease: meta-analysis of hepatitis C , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[19]  X. Didelot,et al.  Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus , 2017, The Journal of antimicrobial chemotherapy.

[20]  M. Suchard,et al.  Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. , 2008, Molecular biology and evolution.

[21]  Daniel J. Wilson,et al.  Within-host evolution of bacterial pathogens , 2016, Nature Reviews Microbiology.

[22]  Loren G. Miller,et al.  Transmission and Microevolution of USA300 MRSA in U.S. Households: Evidence from Whole-Genome Sequencing , 2015, mBio.

[23]  S Bonhoeffer,et al.  Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Betsy Foxman,et al.  A Modeling Framework for the Evolution and Spread of Antibiotic Resistance: Literature Review and Model Categorization , 2013, American journal of epidemiology.

[25]  Guy Baele,et al.  Emerging Concepts of Data Integration in Pathogen Phylodynamics , 2016, Systematic biology.

[26]  Shiwei Lan,et al.  phylodyn: an R package for phylodynamic simulation and inference , 2016, Molecular ecology resources.

[27]  O. Pybus,et al.  Bayesian coalescent inference of past population dynamics from molecular sequences. , 2005, Molecular biology and evolution.

[28]  O. Pybus,et al.  The Epidemic Behavior of the Hepatitis C Virus , 2001, Science.

[29]  Xavier Didelot,et al.  Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study , 2017, PLoS medicine.

[30]  S. Sampling theory for neutral alleles in a varying environment , 2003 .

[31]  O N Bjørnstad,et al.  Predicting the local dynamics of epizootic rabies among raccoons in the United States. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Samuel K. Lai,et al.  Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota , 2015, mBio.

[33]  P. Malani,et al.  National burden of invasive methicillin-resistant Staphylococcus aureus infection. , 2014, JAMA.

[34]  D. Goldfarb A family of variable-metric methods derived by variational means , 1970 .

[35]  P. Planet Life After USA300: The Rise and Fall of a Superbug , 2017, The Journal of infectious diseases.

[36]  J. Hughes,et al.  Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.

[37]  F. Vandenesch,et al.  Demography and Intercontinental Spread of the USA300 Community-Acquired Methicillin-Resistant Staphylococcus aureus Lineage , 2016, mBio.

[38]  C. Hogea,et al.  A basic dynamic transmission model of Staphylococcus aureus in the US population , 2013, Epidemiology and Infection.

[39]  J. Blanton,et al.  Rabies surveillance in the United States during 2014. , 2016, Journal of the American Veterinary Medical Association.

[40]  C. J-F,et al.  THE COALESCENT , 1980 .

[41]  Ethan Romero-Severson,et al.  Phylodynamic Inference across Epidemic Scales , 2017, Molecular biology and evolution.

[42]  David A. Rasmussen,et al.  A dimensionless number for understanding the evolutionary dynamics of antigenically variable RNA viruses , 2011, Proceedings of the Royal Society B: Biological Sciences.

[43]  Erik M. Volz,et al.  Viral phylodynamics and the search for an ‘effective number of infections’ , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[44]  Sergei L. Kosakovsky Pond,et al.  Phylodynamics of Infectious Disease Epidemics , 2009, Genetics.

[45]  Marc A Suchard,et al.  Understanding Past Population Dynamics: Bayesian Coalescent-Based Modeling with Covariates. , 2016, Systematic biology.

[46]  Vladimir N Minin,et al.  Gaussian Process‐Based Bayesian Nonparametric Inference of Population Size Trajectories from Gene Genealogies , 2011, Biometrics.

[47]  J. Hughes,et al.  Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000 , 2003, Emerging infectious diseases.

[48]  Alexei J. Drummond,et al.  A Stochastic Simulator of Birth–Death Master Equations with Application to Phylodynamics , 2013, Molecular biology and evolution.

[49]  Christophe Fraser,et al.  Inferring pandemic growth rates from sequence data , 2012, Journal of The Royal Society Interface.

[50]  Daniel J. Wilson,et al.  Effects of control interventions on Clostridium difficile infection in England: an observational study , 2017, The Lancet. Infectious diseases.

[51]  Trevor Bedford,et al.  Viral Phylodynamics , 2013, PLoS Comput. Biol..

[52]  Erik M. Volz,et al.  Complex Population Dynamics and the Coalescent Under Neutrality , 2012, Genetics.

[53]  E. Volz,et al.  Sampling through time and phylodynamic inference with coalescent and birth–death models , 2014, Journal of The Royal Society Interface.

[54]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.